Published in Br Med Bull on May 01, 1976
Mycobacterium. Bacteriol Rev (1977) 3.20
Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infect Immun (1982) 1.21
The relation between B-cell stimulation and delayed hypersensitivity. The effect of cyclophosphamide pretreatment on antibody production. Immunology (1977) 1.03
Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res (1980) 1.02
Repeated delayed-type hypersensitivity reactions against Mycobacterium lepraemurium antigens at the infection site do not affect bacillary multiplication in C3H mice. Infect Immun (1982) 0.95
Induced immune destruction of long-surviving, H-2 incompatible kidney transplants in mice. J Exp Med (1978) 0.95
Effect of cyclophosphamide treatment on the course of Mycobacterium lepraemurium infection and development of delayed-type hypersensitivity reactions in C57B1 and BALB/c mice. Clin Exp Immunol (1978) 0.93
Suppression of in vitro lymphocyte transformation during an experimental dermatophyte infection. Infect Immun (1979) 0.92
Induction of delayed type hypersensitivity against ultrasonicated Mycobacterium lepraemurium bacilli without simultaneous local reactivity against live bacilli or protective immunity. Clin Exp Immunol (1983) 0.85
Different cellular requirements for inducing contact sensitivity and non-specific unresponsiveness with hapten-conjugated lymphoid cells. Immunology (1985) 0.85
Splenomegaly in murine trypanosomiasis: T cell-dependent phenomenon. Infect Immun (1979) 0.84
Suppression of antibody responses by cells from mice painted with picryl chloride. Immunology (1979) 0.83
Histological studies of the elimination of Leishmania enriettii from skin lesions in the guinea-pig. Br J Exp Pathol (1980) 0.81
Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus. Br J Cancer (1980) 0.78
The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat. Clin Exp Immunol (1979) 0.77
Characterization of lymphocyte subpopulations which exhibit enhanced DNA synthesis in vitro in DNFB contact sensitive guinea-pigs. Immunology (1981) 0.77
Lack of correlation between delayed-type hypersensitivity and host resistance to Plasmodium chabaudi infection. Clin Exp Immunol (1980) 0.77
Cutaneous basophil hypersensitivity and contact sensitivity after cutaneous Trichophyton mentagrophytes infection. Infect Immun (1980) 0.76
The influence of cyclophosphamide and 6-mercaptopurine on the IgG1 and IgG2 immune response in guinea-pigs. Immunology (1981) 0.75
Lymphocyte blastogenic response to human thyroglobulin in Graves' disease, Hashimoto's thyroiditis, and metastatic thyroid cancer. Clin Exp Immunol (1979) 0.75
Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73
New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet (1999) 5.92
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell (1997) 5.39
Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol (1972) 5.29
Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology (1972) 5.18
Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet (1969) 4.92
Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet (1990) 4.01
Barriers to incident reporting in a healthcare system. Qual Saf Health Care (2002) 3.86
Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature (1974) 3.38
B-cell suppression of delayed hypersensitivity reactions. Nature (1974) 3.37
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J (2007) 2.78
Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity. Immunology (1973) 2.65
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax (2002) 2.63
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Studies on the origin and reactive ability in vivo of peritoneal exudate cells in delayed hypersensitivity. Int Arch Allergy Appl Immunol (1967) 2.51
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhanced conventional spin-echo MR? AJNR Am J Neuroradiol (1996) 2.24
Suppressor cells in normal immunisation as a basic homeostatic phenomenon. Nature (1974) 2.23
Cell-mediated immunity in patients with leprosy. Lancet (1969) 2.21
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Complement in acute inflammation. J Pathol (1969) 2.20
Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet (1992) 2.11
A study of the passive cellular transfer of local cutaneous hypersensitivity. I. Passive transfer of delayed hypersensitivity in inbred and outbred guinea-pigs. Int Arch Allergy Appl Immunol (1965) 2.09
An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07
New antibody in early syphilis. Lancet (1970) 1.97
Cytology of the induction of hypersensitivity. Br Med Bull (1967) 1.95
Evidence for circulating immune complexes in lepromatous leprosy. Lancet (1972) 1.94
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors. Cell Immunol (1970) 1.93
Electrophoretic mobility of guinea pig peritoneal exudate cells in hypersensitivity reactions. Int Arch Allergy Appl Immunol (1968) 1.88
Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy. Lancet (1968) 1.88
Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor. Immunology (1969) 1.82
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax (2005) 1.81
Further advances in the management of malignant teratomas of the testis and other sites. Lancet (1983) 1.80
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration (2011) 1.78
Immunological significance of changes in lymph nodes across the leprosy spectrum. Clin Exp Immunol (1971) 1.76
pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc (2001) 1.74
Effect of lymphocyte mediators on macrophages in vitro. A correlation of morphological and cytochemical changes. Clin Exp Immunol (1973) 1.73
Studies on the ability of the subcellular fractions of epidermis, painted in vivo with DNFB, to cause contact sensitization in the guinea pig. Int Arch Allergy Appl Immunol (1970) 1.66
The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig. J Pathol (1971) 1.66
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol (1994) 1.61
Lymphocyte response to antigens. A. Afferent side of sensitization arc. Response of lymphocytes to antigens. Transplantation (1967) 1.58
Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg (1993) 1.57
Granuloma formation in lymph-nodes. J Pathol (1970) 1.54
Bleeding and cupping. Ann R Coll Surg Engl (1983) 1.53
Total synthesis of acetate from CO 2 . V. Determination by mass analysis of the different types of acetate formed from 13 CO 2 by heterotrophic bacteria. J Bacteriol (1972) 1.52
Procedures and the professional: the case of the British NHS. Soc Sci Med (1999) 1.51
Improved cloning efficiency of polymerase chain reaction (PCR) products after proteinase K digestion. Nucleic Acids Res (1991) 1.49
Cell-mediated immunity and lymphocyte transformation in syphilis. Proc R Soc Med (1971) 1.48
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. Rev Infect Dis (1983) 1.46
Reversal by cyclophosphamide of tolerance in contact sensitization. Tolerance induced by prior feeding with DNCB. Immunology (1975) 1.46
Is ultrasound useful for evaluating paediatric inflammatory neck masses? Clin Otolaryngol (2005) 1.45
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology (1991) 1.44
Surface markers on lymphocytes and cells of the mononuclear phagocyte series in skin sections in leprosy. J Pathol (1978) 1.42
Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity (1995) 1.41
Effect of cyclophosphamide on immunological control mechanisms. Immunol Rev (1982) 1.40
Depth of a strong jovian jet from a planetary-scale disturbance driven by storms. Nature (2008) 1.40
Preliminary results on the purification of the chemical sensitizing agents in alcyonidium gelatinosum. Proc R Soc Med (1966) 1.39
Denatured muscle grafts for nerve repair. An experimental model of nerve damage in leprosy. J Bone Joint Surg Br (1990) 1.39
Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma. EMBO J (1985) 1.39
Safety culture assessment in community pharmacy: development, face validity, and feasibility of the Manchester Patient Safety Assessment Framework. Qual Saf Health Care (2005) 1.38
Management of lymphoma patients in a cancer unit: an audit of 15 years' experience in a district general hospital. Clin Oncol (R Coll Radiol) (2001) 1.38
Intrinsic function of a neuronal network - a vertebrate central pattern generator. Brain Res Brain Res Rev (1998) 1.38
Metchnikoff revisited. J R Soc Med (1991) 1.36
Structural analyses of CREB-CBP transcriptional activator-coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains. J Mol Biol (1999) 1.34
Continuous monitoring of arterial oxygen tension using a catheter-tip polarographic electrode in infants. Pediatrics (1976) 1.34
Ultrastructure of cells present in lymph nodes during the development of contact sensitivity. Int Arch Allergy Appl Immunol (1966) 1.34
Mechanisms of reactions in leprosy. Int J Lepr Other Mycobact Dis (1972) 1.33
Immunological significance of lysosomes with lymphocytes in vivo. Nature (1965) 1.32
Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med (2001) 1.31
Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer (1983) 1.31
Cell-mediated immunological processes in leprosy. Bull World Health Organ (1969) 1.31
Release of skin reactive factor from guinea-pig lymphocytes by mitogens. Nature (1970) 1.30
Basophilic leukocytes in delayed hypersensitivity reactions. J Immunol (1974) 1.29
Luminescence imaging microscopy and lifetime mapping using kinetically stable lanthanide(III) complexes. J Photochem Photobiol B (2000) 1.27
Epicutaneous induction of hyporeactivity in contact sensitization. Demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene. Immunology (1975) 1.25
Comparison of mycobacterial granulomas in guinea-pig lymph nodes. J Pathol (1982) 1.25
A disposable catheter-tip transducer for continuous measurement of blood oxygen tension in vivo. Biomed Eng (1971) 1.25
An experimental model for the investigation of the cellular basis of desensitization in contact sensitivity. Int Arch Allergy Appl Immunol (1965) 1.24
The immunological significance of histological changes in the spleen and liver in mouse malaria. Clin Exp Immunol (1973) 1.23
The relation of immune depression and B-cell stimulation during the development of delayed hypersensitivity to soluble antigens. Immunology (1977) 1.23
The construction, identification and partial characterization of plasmids containing guinea-pig milk protein complementary DNA sequences. Biochem J (1981) 1.21
Studies on contact hypersensitivity to chromium compounds. Prog Allergy (1973) 1.21
AIDS and leprosy. Lepr Rev (1988) 1.21